Pari-Mutuel Betting Supervision Regulations (SOR/91-365)

Regulations are current to 2017-11-20 and last amended on 2017-03-02. Previous Versions

  •  (1) When a person other than a test inspector collects an official sample, the person shall, under the supervision of a test inspector,

    • (a) use approved paraphernalia provided by a test inspector;

    • (b) ensure that the official sample container is visible to the test inspector at all times; and

    • (c) sign the documentation that accompanies the official sample.

  • (2) No person shall remove a horse that has been chosen to undergo a test from a retention area unless authorized to do so by the test inspector supervising the collection.

  • SOR/2000-163, s. 14.

 [Repealed, SOR/2000-163, s. 15]

 On completion of an analysis of an official sample, an official chemist shall classify the official sample as positive and issue a certificate of positive analysis if he or she has determined that

  • (a) with respect to a drug set out in section 1 of the schedule,

    • (i) for any drug other than furosemide in respect of any horse, or for furosemide in respect of a horse that is not on an EIPH list, the drug is present in the official sample, or

    • (ii) for furosemide in respect of a horse that is on an EIPH list, furosemide is not present in the official sample of urine or it is present in the official sample of blood in a quantity indicating that furosemide was administered to the horse otherwise than in the manner set out in paragraph 170.1(1)(e);

  • (b) with respect to a drug set out in section 2 of the schedule, the drug is present in the official sample in a concentration that exceeds the quantitative limit set out for the drug in that section; and

  • (c) with respect to a drug set out in section 3 of the schedule,

    • (i) if the owner or trainer complies with section 170, the drug is present in the official sample in a concentration that exceeds the quantitative limit set out for the drug in section 3 of the schedule, or

    • (ii) if the owner or trainer does not comply with section 170, the drug is present in the official sample.

  • SOR/91-518, s. 4;
  • SOR/2000-163, s. 16.

 [Repealed, SOR/2000-163, s. 17]

 Unless otherwise authorized by the Executive Director, an official chemist shall not disclose the details of any analysis to anyone other than the Executive Director, an officer or an official of the appropriate Commission.

  • SOR/93-255, s. 3.

 [Repealed, SOR/2000-163, s. 18]

Statement and sample

 With respect to a drug set out in section 3 of the schedule and administered to a horse entered in a race at a race-course, the owner or trainer of the horse shall provide a test inspector

  • (a) at the race-course, not later than one half hour before the post time of the race in which the horse is entered, with a statement signed by the horse’s veterinarian or trainer that identifies the horse, including its sex, and the race in which it is entered and indicates the brand name, generic name, route of administration, dosage and time of the last administration of the drug to the horse; and

  • (b) immediately after the race, if the horse has been chosen to undergo a test, with an official sample of blood collected in accordance with section 162.

  • SOR/2000-163, s. 19;
  • SOR/2011-169, s. 75;
  • SOR/2017-8, s. 26.

EIPH Program

  •  (1) Where an exercise-induced pulmonary hemorrhage (EIPH) program for horses, established by the appropriate Commission, is implemented at a race-course of an association, the Executive Director shall, subject to the other requirements of these Regulations, approve pari-mutuel betting at that race-course where the Commission, at that race-course,

    • (a) establishes and maintains an up-to-date EIPH list and provides the test inspector with a copy of it at the beginning of every racing card;

    • (b) ensures that any horse on the EIPH list remains on that list for a period of at least 100 days;

    • (c) maintains an accurate medication record in respect of every horse on the EIPH list;

    • (d) prohibits any horse on the EIPH list from racing after a recurrence of bleeding during or after a race that is confirmed by a veterinarian designated by the appropriate Commission, for a minimum period of

      • (i) 14 consecutive days after that recurrence,

      • (ii) 90 consecutive days after the second recurrence, and

      • (iii) 365 consecutive days after the third recurrence;

    • (e) verifies that any horse on the EIPH list receives the drug furosemide, in an amount not less than 150 mg and not more than 250 mg, intravenously, four hours plus or minus fifteen minutes before the post time of the race in which the horse is entered;

    • (f) ensures that any horse on the EIPH list that did not receive the drug furosemide in accordance with paragraph (e) is scratched;

    • (g) where any horse on the EIPH list did not receive the drug furosemide, as evidenced by the absence of that drug in an analysis of an official sample of urine collected from that horse, prohibits the horse from racing for a minimum period of 14 consecutive days; and

    • (h) ensures that an officer is given, on request, access to records maintained for the EIPH list.

  • (1.1) For the purposes of paragraph (1)(a), the Commission shall add a horse to the list if the following conditions are met:

    • (a) the owner or trainer of the horse and the consulting veterinarian licensed by the appropriate Commission have determined that it would be in the horse’s best interest to be placed on the list; and

    • (b) the veterinarian designated by the appropriate Commission has endorsed that determination.

  • (2) Where a horse on an EIPH list is chosen to undergo a test pursuant to subsection 161(1), the owner or trainer of the horse shall provide a test inspector, immediately after the race, with an official sample of blood collected in accordance with section 162.

  • SOR/91-518, s. 5;
  • SOR/93-143, s. 1;
  • SOR/93-255, s. 3;
  • SOR/95-475, s. 3(F);
  • SOR/2000-163, s. 20;
  • SOR/2011-169, s. 76.

 [Repealed, SOR/2011-169, s. 77]

Prohibitions

 No person shall

  • (a) administer or permit the administration of a drug to a horse that is entered in a race in such a manner that a certificate of positive analysis would be issued under section 165 with respect to that horse;

  • (b) tamper with a horse before, during or after a race in such a manner as to interfere with the collection or analysis of an official sample;

  • (c) unless otherwise permitted by a test inspector or a veterinarian designated by the appropriate Commission, administer, after a race, anything except drinking water to a horse that has been chosen to undergo a test under subsection 161(1), until the horse is discharged;

  • (d) interfere with the work of any person who is undertaking activities relating to an equine drug control program;

  • (e) interfere with the collection or analysis of an official sample;

  • (f) substitute another horse for any horse that has been chosen to undergo a test pursuant to subsection 161(1); or

  • (g) substitute or misrepresent the contents of an official sample container.

  • SOR/2000-163, s. 21;
  • SOR/2011-169, ss. 78, 80.

 [Repealed, SOR/2000-163, s. 21]

 
Date modified: